<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-282 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-282</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-282</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-5.html">extraction-schema-5</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <p><strong>Paper ID:</strong> paper-9d33ca82117566dad75eedb25d2fe6fa017de3c4</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/9d33ca82117566dad75eedb25d2fe6fa017de3c4" target="_blank">Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma.</a></p>
                <p><strong>Paper Venue:</strong> Oncology Letters</p>
                <p><strong>Paper TL;DR:</strong> The present study results indicated that the EGFR and KRAS profiles, including mutations and CNGs, differ between Asian and non-Asian individuals with lung adenocarcinoma, suggesting that ethnicity strongly affects the molecular characteristics of lungAdenocARCinoma.</p>
                <p><strong>Paper Abstract:</strong> Mutations or copy number gains (CNGs) of the EGFR and KRAS genes are representative alterations in lung adenocarcinomas that are individually associated with patient characteristics such as ethnicity, smoking status and gender. However, the effects of combinations of these genetic alterations have not been statistically examined. The present study analyzed previously examined lung adenocarcinoma cases in Asian (n=166) and non-Asian (n=136) individuals in whom all four EGFR and KRAS alterations had been studied. The polynomial logistic regression models were used following adjustment for gender and smoking status, and using patients without any type of EGFR/KRAS alterations as a reference. Between the two ethnic groups, EGFR CNGs (gEGFR) occurred more frequently than EGFR mutations (mEGFR) (46 vs. 38% in Asians; 21 vs. 10% in non-Asians), whereas KRAS mutations (mKRAS) were more frequent than KRAS CNGs (gKRAS) (13 vs. 7% and 35 vs. 4%, respectively). Additionally, gEGFR and gKRAS occurred significantly more frequently in respective mutant cases, and all EGFR alterations were almost exclusive of all KRAS alterations. The polynomial logistic regression models confirmed that all types of EGFR alterations were significantly more frequent among Asian individuals than among non-Asian individuals, independent of gender and smoking status (odds ratios, 2.36-6.67). KRAS alterations occurred less frequently among Asian individuals than among non-Asian individuals, although a significant difference was not detected. The present study results indicated that the EGFR and KRAS profiles, including mutations and CNGs, differ between Asian and non-Asian individuals with lung adenocarcinoma, suggesting that ethnicity strongly affects the molecular characteristics of lung adenocarcinoma.</p>
                <p><strong>Cost:</strong> 0.01</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e282.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e282.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>mEGFR (this study)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR activating mutations in lung adenocarcinoma (mutations only)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Observed prevalence and associations of EGFR somatic (activating) mutations in a multi-country cohort of resected lung adenocarcinomas, with direct comparison between Asian and non-Asian patients and adjustment for gender and smoking.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>302 surgically resected lung adenocarcinomas; Asian n=166 (Japanese and other Asian samples collected in Japan and North America), Non-Asian n=136 (predominantly Caucasian with small numbers of African-American and Mexican-American); samples obtained from Japan (n=148), United States (n=87), Australia (n=22), Canada (n=45).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td>38% (63/166)</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td>10.3% (14/136) â€” non-Asian group composed mainly of Caucasian (n=128), plus 4 African-American and 4 Mexican-American</td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td>Strong association with never-smokers: overall mEGFR present in 49.6% of never-smokers vs 10.2% of ever-smokers (whole cohort). Asian group had higher proportion of never-smokers (45.2%) vs non-Asian (29.4%). mEGFR enriched in Asian and in never-smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Lung adenocarcinoma (all cases in this analysis were adenocarcinomas).</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Smoking status (never vs ever) analyzed and adjusted for; authors argue immigrant Asian cases in Western countries retain high EGFR alteration frequency, suggesting environmental factors (as measured by geography/immigration) are unlikely to fully explain ethnic differences. No other environmental exposures (e.g., air pollution, cooking fumes) are specifically analyzed or reported.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Authors infer an ethnicity/ancestry effect (genetic background) as an important determinant of EGFR molecular spectrum; no specific germline polymorphisms or ancestry markers are identified in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>No detailed molecular mechanism is proposed; authors suggest that ethnic (ancestral/genetic) background influences the molecular characteristics of lung adenocarcinoma (higher propensity for EGFR activation by mutation in Asians), and that this is independent of gender and smoking distribution.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td>Adjusted odds ratios (Asian vs non-Asian, reference = cases without any EGFR/KRAS alteration): Mut alone/None OR = 4.94 (95% CI 1.95-12.6; P<0.001); Mut/None OR = 4.76 (95% CI 2.30-9.83; P<0.001); Mut or CNG/None OR = 4.24 (95% CI 2.29-7.86; P<0.001).</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Gender and smoking status differ between ethnic groups (Asians had more females and more never-smokers); these were adjusted for in polynomial logistic regression. Other possible confounders discussed: mixed geographic sampling, small subgroup sizes (some ORs not evaluable due to zero counts), and potential selection/referral bias; authors argue immigrant Asian cases maintain EGFR patterns, reducing likelihood of purely environmental confounding.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>EGFR activating mutations are significantly more frequent in Asian versus non-Asian lung adenocarcinoma patients (38% vs 10.3%), independent of gender and smoking status (adjusted ORs ~4.8-4.9). mEGFR is strongly associated with female gender and never-smoking status. The authors conclude ethnicity strongly affects EGFR mutation prevalence.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma.', 'publication_date_yy_mm': '2015-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e282.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e282.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation prevalence in lung cancer across different ethnic populations, particularly comparing East Asian and non-Asian populations, including frequencies, patient characteristics, environmental factors, and proposed explanations for ethnic differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>gEGFR (this study)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR copy number gains (CNG) in lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Prevalence and ethnic comparison of EGFR gene copy number gain (CNG) in the same cohort, including relationship to EGFR mutation status and clinical factors.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Same cohort of 302 surgically resected lung adenocarcinomas (Asian n=166; non-Asian n=136) with qPCR-based copy number assessment (LINE-1 reference); CNG defined as relative copy number >3.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_asian</strong></td>
                            <td>EGFR copy number gain (gEGFR) present in 45.8% (76/166) of Asian patients (reported as 46%).</td>
                        </tr>
                        <tr>
                            <td><strong>mutation_frequency_non_asian</strong></td>
                            <td>gEGFR present in 20.6% (28/136) of non-Asian patients (reported as 21%).</td>
                        </tr>
                        <tr>
                            <td><strong>has_comparative_ethnic_data</strong></td>
                            <td>True</td>
                        </tr>
                        <tr>
                            <td><strong>patient_smoking_status</strong></td>
                            <td>gEGFR associated with never-smokers overall: 41.7% of never-smokers had gEGFR vs 29.9% of ever-smokers (P=0.046). gEGFR occurred more frequently in Asian subgroups across smoking/gender strata compared with corresponding non-Asian groups.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_histology</strong></td>
                            <td>Lung adenocarcinoma.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Smoking status analyzed; authors note Western-collected never-smoker NSCLC samples also show gEGFR in other studies, and immigrant Asian patients retain high EGFR alteration frequency, suggesting environmental exposures alone unlikely to explain ethnic gEGFR differences.</td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Authors suggest ethnic/genetic background may influence prevalence of EGFR CNGs (no specific genetic loci or polymorphisms are identified in this paper).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>No mechanistic molecular explanation given; authors note EGFR tends to be activated more often by CNG than by mutation in this dataset and that gEGFR is enriched in cases with mEGFR, implying selection for combined activation in certain tumors and an ethnic predisposition to EGFR activation.</td>
                        </tr>
                        <tr>
                            <td><strong>odds_ratio_or_risk</strong></td>
                            <td>Adjusted ORs (Asian vs non-Asian, reference = no EGFR/KRAS alteration): CNG alone/None OR = 2.43 (95% CI 1.17-5.07; P=0.017); CNG/None OR = 2.36 (95% CI 1.30-4.28; P=0.005).</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Differences in gender and smoking distributions across ethnic groups (adjusted for in analysis). Small numbers for some CNG/KRAS combination categories limited evaluation (NE entries in table). Possible sampling bias across collection sites.</td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>EGFR copy number gains are significantly more frequent in Asian than non-Asian adenocarcinoma patients (46% vs 21%), and gEGFR is more common in never-smokers and in tumors already harboring EGFR mutations; ethnicity remains a significant predictor after adjusting for smoking and gender.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma.', 'publication_date_yy_mm': '2015-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy <em>(Rating: 2)</em></li>
                <li>Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib <em>(Rating: 2)</em></li>
                <li>EGFR gene and protein and gefitinib sensitivity in non-small-cell lung cancer <em>(Rating: 2)</em></li>
                <li>Genomic profiles specific to patient ethnicity in lung adenocarcinoma <em>(Rating: 2)</em></li>
                <li>Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer <em>(Rating: 2)</em></li>
                <li>Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America <em>(Rating: 2)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>